Related Experiment Video
Updated: Oct 27, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Type O blood group associates with higher anti-JC polyomavirus antibody levels
Pia Frenken1, Hans-Peter Hartung2, Tomas Olsson3
1Institute for Virologie, Universitätsklinikum Düsseldorf, Düsseldorf, Germany.
Background:
Patients with multiple sclerosis (MS) and high anti-JC polyomavirus (JCPyV) antibodies in blood have an increased risk for the development of progressive multifocal leukoencephalopathy (PML) when treated for MS. To test the hypothesis that type O blood group associates with anti-JCPyV antibody levels and the risk of developing PML, we characterized ABO blood group antigen on blood samples of 62 patients with PML, and 64 MS controls without PML.
Methods:
Monocentric retrospective cohort study. Anti-JCPyV antibody levels in arbitrary units (AU) were determined in sera using an ELISA-based method, and blood group specific antibodies using standardised test erythrocytes.
Results:
Anti-JCPyV antibody levels were higher in individuals with blood group O compared with all other blood groups (O: median AU: 129; not O: median AU: 53; p = .005). This association was not observed for the closely related BK virus. Of the 62 patients with PML, 29 (47%, 95% confidence interval (CI) 35%-59%) were of blood group O, which showed a nonsignificant trend to differ from the expected distribution in the German population (41%), and the MS controls studied (36%, 95% CI 25%-48%).
Conclusion:
The ABO blood group O antigen associates with higher anti-JCPyV antibody levels and may impact the risk of the later development of PML. The overrepresentation of blood group O in cases with PML was in line with a previous publication. Larger studies are warranted to assess a potential value of host genetic markers, such as the ABO status, for PML risk prediction during immunotherapy.
Insights
Individuals with blood group O have higher anti-JC polyomavirus (JCPyV) antibody levels, potentially increasing the risk of progressive multifocal leukoencephalopathy (PML) in multiple sclerosis patients. Further research is needed to confirm this association for PML risk prediction.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- Patients with multiple sclerosis (MS) treated with certain therapies face an increased risk of progressive multifocal leukoencephalopathy (PML).
- High levels of anti-JC polyomavirus (JCPyV) antibodies in the blood are a known risk factor for developing PML in MS patients.
Purpose of the Study:
- To investigate the association between ABO blood group type and anti-JCPyV antibody levels.
- To determine if blood group O influences the risk of developing PML in individuals with MS.
Main Methods:
- Retrospective cohort study involving 62 PML patients and 64 MS controls.
- Quantification of anti-JCPyV antibody levels using ELISA.
- Characterization of ABO blood group antigens from blood samples.
Main Results:
- Individuals with blood group O exhibited significantly higher anti-JCPyV antibody levels compared to other blood groups (p = .005).
- A trend, though not statistically significant, indicated a higher prevalence of blood group O among PML patients (47%) compared to MS controls (36%).
- No association was found between blood group and antibodies against the related BK virus.
Conclusions:
- The ABO blood group O antigen is associated with elevated anti-JCPyV antibody titers.
- Blood group O may play a role in the risk of developing PML, particularly in the context of MS immunotherapy.
- Larger studies are recommended to explore the utility of ABO blood group as a predictive marker for PML risk.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
The ABO Blood Group
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Rh Blood Group
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...

